Evidence map›Paper›PMID 20621348›Full record

Trial reportThe Journal of allergy and clinical immunology2010

Risk of cataracts in the Childhood Asthma Management Program Cohort.

Hengameh H Raissy, Alice L Sternberg, Paul Williams, Aaron Jacobs, H William Kelly, CAMP Research Group

Open access · bronzeAbstract readLetterMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Inhaled corticosteroids in lung diseases.American journal of respiratory and critical care medicine · 2013
    Article
  6. Article
  7. Stepping down asthma treatment: how and when.Current opinion in pulmonary medicine · 2012
    Review
  8. Advances in pediatric asthma in 2010: addressing the major issues.The Journal of allergy and clinical immunology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hengameh H Raissy
Alice L Sternberg
Paul Williams
Aaron Jacobs
H William Kelly
CAMP Research Group
University of New Mexico · USJohns Hopkins University · USUniversity of Washington · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI WALDERS, NATALIE · 1985 to 2008
$52.6M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI POLONSKY, KENNETH S · 1985 to 2007
$25.4M
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDYM01RR002719 · NCRR · JOHNS HOPKINS UNIVERSITY · PI EARLEY, CHRISTOPHER J · 1986 to 2007
$20.2M
CAMPCS/3U01HL075408 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 2003 to 2010
$4.9M
CAMP Continuation Study/Phase 3U01HL075419 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI FUHLBRIGGE, ANNE L · 2003 to 2010
$2.0M
CAMP Continuation Study/Phase 3U01HL075409 · NHLBI · ASTHMA, INC. · PI WILLIAMS, PAUL V · 2003 to 2010
$1.6M
CAMP Continuation Study/Phase 3U01HL075417 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ADKINSON, N FRANKLIN · 2003 to 2010
$1.4M
CAMP Contiunation Study/Phase 3U01HL075416 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 2003 to 2010
$1.4M
CAMP Continuation Study/Phase 3U01HL075415 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZEIGER, ROBERT S · 2003 to 2010
$1.3M
CAMP Continuation Study/Phase 3U01HL075232 · NHLBI · WASHINGTON UNIVERSITY · PI STRUNK, ROBERT · 2003 to 2010
$1.3M
CAMP Continuation Study/Phse 2 (CAMPCS/2)U01HL075420 · NHLBI · UNIVERSITY OF NEW MEXICO · PI RAISSY, HENGAMEH H · 2003 to 2010
$1.1M
CAMP Continuation Study/Phase 3U01HL075407 · NHLBI · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI GRASEMANN, HARTMUT · 2003 to 2010
$1.0M
NCRR NIH HHS M01 RR000036NCRR NIH HHS M01 RR000051NCRR NIH HHS M01RR00051NCRR NIH HHS M01 RR002719NCRR NIH HHS M01RR0099718-24NCRR NIH HHS M01RR02719-14NCRR NIH HHS RR00036NHLBI NIH HHS N01 HR016044NHLBI NIH HHS N01-HR-16044NHLBI NIH HHS N01-HR-16045NHLBI NIH HHS N01-HR-16046NHLBI NIH HHS N01-HR-16047NHLBI NIH HHS N01-HR-16048NHLBI NIH HHS N01-HR-16049NHLBI NIH HHS N01-HR-16050NHLBI NIH HHS N01-HR-16051NHLBI NIH HHS N01-HR-16052NHLBI NIH HHS U01 HL075232NHLBI NIH HHS U01HL075232NHLBI NIH HHS U01 HL075407NHLBI NIH HHS U01HL075407NHLBI NIH HHS U01 HL075408NHLBI NIH HHS U01HL075408NHLBI NIH HHS U01 HL075409NHLBI NIH HHS U01HL075409NHLBI NIH HHS U01 HL075415NHLBI NIH HHS U01HL075415NHLBI NIH HHS U01 HL075416NHLBI NIH HHS U01HL075416NHLBI NIH HHS U01 HL075417NHLBI NIH HHS U01HL075417NHLBI NIH HHS U01 HL075419NHLBI NIH HHS U01HL075419NHLBI NIH HHS U01 HL075420NHLBI NIH HHS U01HL075420
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAnti-Allergic AgentsAsthmaBudesonideCataractChildChild, PreschoolFemaleFollow-Up StudiesGlucocorticoidsHumansInfantMaleNedocromilRisk FactorsAnti-Allergic AgentsBudesonideGlucocorticoidsNedocromil

Identifiers

PMID20621348
PMCPMC3049457
OpenAlexW2009073508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.